Latest Manufacturing News

Wide Open Agriculture (ASX: WOA) has taken a significant step towards a capital-light production model by signing a non-binding framework agreement with Proeon Foods for contract manufacturing of its lupin-based ingredients, including exclusive Indian distribution rights.

Sunrise Energy Metals has landed a conditional US$400 million loan commitment from the U.S. Department of War’s Office of Strategic Capital to back its Syerston Scandium Project, while also initiating plans for a U.S. securities listing.

De.mem Limited is poised for a record 2026, driven by 29 consecutive quarters of cash receipts growth, positive operating cashflow, and strategic expansion into the gold mining sector through Core Chemicals.

Rimfire Pacific Mining has appointed Bronwyn Barnes as Executive Chair and secured $2.3 million in a placement to advance its scandium exploration and development strategy.

James Hardie Industries posted a 64% jump in Q1 FY27 net sales to $1.475 billion, powered by the AZEK acquisition and solid organic growth. The company exceeded EBITDA guidance and raised its full-year outlook, targeting robust sales and cash flow growth amid cautious housing market assumptions.

Wellnex Life has agreed to sell its Pain Away brand to Mentholatum Australasia for up to A$21.3 million, aiming to wipe out debt and sharpen its strategic focus.

Clarity Pharmaceuticals has presented compelling clinical evidence that its investigational 64Cu-SAR-bisPSMA diagnostic and 67Cu-SAR-bisPSMA therapeutic candidates outperform current standards in prostate cancer care, positioning the company for regulatory and commercial milestones.

The Calmer Co. has secured a long-term supply agreement for premium noble kava from Papua New Guinea and Vanuatu, underpinning its manufacturing growth and diversified Pacific sourcing network.

Argent BioPharma's licensing partner Splash Beverage Group has launched the US veterinary development program for CannEpil®, targeting companion-animal oncology and chronic pain. Led by industry veteran Dr Hunter Land, the initiative follows a defined FDA regulatory pathway and could broaden CannEpil®’s commercial footprint beyond human neurology.

PPK Group is set to return value to shareholders through a $2.5 million on-market share buyback following the profitable divestment of its Craig International Ballistics stake.

Dimerix CEO Dr Nina Webster detailed the company’s geographic and product diversification at the Bioshares Summit, spotlighting the commercial potential of DMX-200 and the newly acquired Phase 2 asset DMX-652 targeting acute kidney injury.

Connected Minerals Ltd has successfully raised $4.5 million through a placement, clearing the final hurdle to acquire an 80% stake in the Bailundo carbonatite project in Angola.